相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

CD300ld封锁克服了晚期瘤中PMN-MDSC介导的疫苗耐药性

Xianglei Wang¹, Shiyao Xue^1,2, Yuwei Li³

¹Institute of Pediatrics of Children's Hospital of Fudan University, Shanghai Key Laboratory of Medical Epigenetics, Shanghai Key Laboratory of Oncology Target Discovery and Antibody Drug Development, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.

Journal for immunotherapy of cancer

|January 16, 2026

概括

晚期癌症疫苗面临的耐药性是由于增加了免疫抑制性髓质衍生抑制细胞 (PMN-MDSCs). 在这些细胞上阻断CD300ld可以恢复疫苗对晚期瘤的疗效.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
纳米技术纳米技术

背景情况:

癌症疫苗看起来很有前途,但与晚期瘤作斗争.
抵抗机制需要阐明,以改善治疗解决方案.
一种激活STING的PC7A纳米疫苗已经证明了先前的抗瘤疗效.

研究的目的:

在晚期瘤中研究纳米疫苗耐药性的机制.
确定克服癌症疫苗治疗障碍的策略.
评估PMN-MDSCs和CD300ld在疫苗耐药性的作用.

主要方法:

在早期和晚期B16-OVA黑色素瘤和TC-1癌症模型中评估PC7A纳米疫苗的疗效.
分析了瘤微环境,专注于多态核核髓衍生抑制细胞 (PMN-MDSCs).
利用CD300ld淘汰赛小鼠和重组蛋白来研究CD300ld阻断策略.

主要成果:

PC7A纳米疫苗对晚期瘤的影响很小,增加PMN-MDSC透和免疫抑制.
CD300ld淘汰赛取消了PMN-MDSC的招募和抑制,恢复了疫苗的疗效.
通过重组蛋白来阻止CD300ld,在晚期瘤中克服了对各种癌症疫苗的抵抗力.

结论:

晚期瘤疫苗接种增强PMN-MDSC免疫抑制,导致疫苗耐药性.
PMN-MDSCs是晚期癌症中抗性的关键调解者.
CD300ld封锁是一种有前途的策略,可以提高癌症疫苗在晚期疾病中的疗效.

关键词:

免疫抑制是一种免疫抑制.免疫疗法免疫疗法作为一个中性恋者.疫苗疫苗疫苗疫苗

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.